Insider · CIK 0001699263
Thomas Martin Nuckols
Files at DXYN (DIXIE GROUP INC). First filing -, latest -.
Thomas Martin Nuckols files SEC Form 4 as officer at DXYN (DIXIE GROUP INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas Martin Nuckols has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | DXYN DIXIE GROUP INC | FTax withholding Common Stock, $3 par value | -4,383 | $0.40 | $1,753 | 180,158 | Apr 1, 2026 |
| Mar 12, 2026 | DXYN DIXIE GROUP INC | AGrant or award Common Stock, $3 par value | +27,788 | $0.00 | $0 | 184,541 | Mar 13, 2026 |
| Apr 10, 2025 | DXYN DIXIE GROUP INC | FTax withholding Common Stock, $3 par value | -7,810 | $0.43 | $3,358 | 156,753 | Apr 14, 2025 |
Questions about Thomas Martin Nuckols
Answered from the filings on this page, as of the latest one.
Is Thomas Martin Nuckols buying or selling?
Thomas Martin Nuckols has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas Martin Nuckols's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Martin Nuckols has 0.
Where does Thomas Martin Nuckols file Form 4?
Thomas Martin Nuckols has filed Form 4 at DXYN (DIXIE GROUP INC) as Executive Vice President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.